Up a level |
Waters, Laura, Winston, Alan, Reeves, Iain, Boffito, Marta, Churchill, Duncan, Cromarty, Ben, Dunn, David, Fink, Douglas, Fidler, Sarah, Foster, Caroline et al (show 14 more authors)
(2022)
BHIVA guidelines on antiretroviral treatment for adults living with HIV-1 2022.
HIV MEDICINE, 23 (S5).
pp. 3-115.
Geretti, Anna Maria ORCID: 0000-0002-3670-6588, Brook, Gary, Cameron, Claire, Chadwick, David, French, Neil ORCID: 0000-0003-4814-8293, Heyderman, Robert, Ho, Antonia ORCID: 0000-0003-1465-3785, Hunter, Michael, Ladhani, Shamez, Lawton, Mark et al (show 4 more authors)
(2016)
British HIV Association Guidelines on the Use of Vaccines in HIV-Positive Adults 2015.
HIV MEDICINE, 17 (S3).
S2-S81.
Bracchi, Margherita, van Halsema, Clare, Post, Frank, Awosusi, Funmi, Barbour, Alison, Bradley, Steve, Coyne, Katherine, Dixon-Williams, Esther, Freedman, Andrew, Jelliman, Pauline et al (show 7 more authors)
(2019)
British HIV Association guidelines for the management of tuberculosis in adults living with HIV 2019.
[Report]
Churchill, Duncan, Waters, Laura, Ahmed, Nadia, Angus, Brian, Boffito, Marta, Bower, Mark, Dunn, David, Edwards, Simon, Emerson, Carol, Fidler, Sarah et al (show 21 more authors)
(2016)
British HIV Association guidelines for the treatment of HIV-1-positive adults with antiretroviral therapy 2015.
HIV MEDICINE, 17 (S4).
S2-S104.
Gotham, Dzintars, Fortunak, Joseph, Pozniak, Anton, Khoo, Saye ORCID: 0000-0002-2769-0967, Cooke, Graham, Nytko, Frederick EIII and Hill, Andrew
(2017)
Estimated generic prices for novel treatments for drug-resistant tuberculosis.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 72 (4).
pp. 1243-1252.
Gurjar, Rohan, Dickinson, Laura ORCID: 0000-0001-5557-9396, Carr, Daniel, Stohr, Wolfgang, Bonora, Stefano, Owen, Andrew ORCID: 0000-0002-9819-7651, D'Avolio, Antonio, Cursley, Adam, De Castro, Nathalie, Fatkenheuer, Gerd et al (show 6 more authors)
(2022)
Influence of <i>UGT1A1</i> and <i>SLC22A6</i> polymorphisms on the population pharmacokinetics and pharmacodynamics of raltegravir in HIV-infected adults: a NEAT001/ANRS143 sub-study.
PHARMACOGENOMICS JOURNAL, 23 (1).
pp. 14-20.
Jackson, Akil ORCID: 0000-0002-4574-544X, Else, Laura, Higgs, Christopher, Karolia, Zeenat, Khoo, Saye ORCID: 0000-0002-2769-0967, Back, David, Devitt, Emma, Pozniak, Anton and Boffito, Marta
(2018)
Pharmacokinetics and pharmacodynamics of the nucleoside sparing dual regimen containing rilpivirine plus darunavir/ritonavir in treatment-naive HIV-1-infected individuals.
HIV CLINICAL TRIALS, 19 (1).
pp. 31-37.
Dickinson, Laura ORCID: 0000-0001-5557-9396, Gurjar, Rohan, Stoehr, Wolfgang, Bonora, Stefano, Owen, Andrew ORCID: 0000-0002-9819-7651, D'Avolio, Antonio, Cursley, Adam, Molina, Jean-Michel, Faeetkenheuer, Gerd, Vandekerckhove, Linos et al (show 5 more authors)
(2020)
Population pharmacokinetics and pharmacogenetics of ritonavir-boosted darunavir in the presence of raltegravir or tenofovir disoproxil fumarate/emtricitabine in HIV-infected adults and the relationship with virological response: a sub-study of the NEAT001/ANRS143 randomized trial.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 75 (3).
pp. 628-639.
Marzolini, Catia, Kuritzkes, Daniel R, Marra, Fiona, Boyle, Alison, Gibbons, Sara, Flexner, Charles, Pozniak, Anton, Boffito, Marta, Waters, Laura, Burger, David et al (show 2 more authors)
(2022)
Recommendations for the Management of Drug-Drug Interactions Between the COVID-19 Antiviral Nirmatrelvir/Ritonavir (Paxlovid) and Comedications.
CLINICAL PHARMACOLOGY & THERAPEUTICS, 112 (6).
pp. 1191-1200.
Venter, WD Francois, Sokhela, Simiso, Calmy, Alexandra, Mkhondwane, Luckyboy, Bosch, Bronwyn, Chandiwana, Nomathemba, Hill, Andrew, Sekwese, Kenly, Mashabane, Nkuli, Pozniak, Anton et al (show 11 more authors)
(2021)
Weight gain stopping/switch rules for antiretroviral clinical trials.
AIDS, 35 (Suppl ).
S183-S188.
Schultze, Anna, Paredes, Roger, Sabin, Caroline, Phillips, Andrew N, Pillay, Deenan, Mackie, Nicola, Castagna, Antonella, Chadwick, David, Falconer, Karolin, Geretti, Anna Maria ORCID: 0000-0002-3670-6588 et al (show 9 more authors)
(2018)
The association between detected drug resistance mutations and CD4<SUP>+</SUP> T-cell decline in HIV-positive individuals maintained on a failing treatment regimen.
ANTIVIRAL THERAPY, 23 (2).
pp. 105-116.